Modal Title
Course Description
Chlamydia is the most frequently reported sexually transmitted infection in the United States. Often asymptomatic, however, symptoms do occur when manifested as conjunctivitis. Chlamydia trachomatis can manifest in ocular tissue in three forms; trachoma, neonatal inclusion conjunctivitis, and adult inclusion conjunctivitis. Trachoma is the number one cause of infectious vision loss worldwide. Neonatal inclusion conjunctivitis can be spread vertically from mother to child during vaginal birth and can evolve systemically into pneumonia. Screening, diagnosis, and treatment are discussed. This course is presented by both an optometrist and registered nurse; highlighting interprofessional collaboration and improved patient care.
Intended Audience
- Physicians
- Physician Assistants
- Registered Nurses
- Advanced Practice Registered Nurses
- Optometrists
Learning Objectives
At the completion of this activity, healthcare providers will be able to:
- Describe manifestations of the 3 chlamydial infections of the eye: trachoma, neonatal inclusion conjunctivitis, and adult inclusion conjunctivitis.
- Summarize the SAFE strategy to prevent trachoma.
- Connect CDC prenatal chlamydial screening recommendations to neonatal inclusion conjunctivitis prevention.
- Articulate when and how to gather sexual health history while managing a patient with red eye complaints.
- Contrast the 3 antibiotics indicated on the CDC’s current STI treatment guidelines.
- Describe how interprofessional collaboration can assist with prevention, screening, diagnosis, and management of chlamydial eye infections.
Details
- Credit/Contact Hours
- 1
- Pharmacotherapy Hours
- 0.25
- Faculty
-
- Erika Anderson, OD, FAAO
Staff Optometrist / Independent Contractor, Eye Associates of New Mexico - Grace Murphy, MSN/MPH, RN
Lecturer I, University of New Mexico College of Nursing
- Erika Anderson, OD, FAAO
- Development Team
-
- Trisha Moreno
- Language
-
- English
- Release Date
- March 13, 2024
- Expiration Date
- March 13, 2027
- Instructional Methods
-
- Assessment Review with Rationale
- Case Studies
- Ungraded Self Assessment-Lesson Recall
- Video Narration
- Assessment
-
- Autograded and Quiz Retakes Allowed
- Daily CE Broker Reporting for Registered Boards
- Graded Final Quiz
- Passing 80%+
State/Local Approvals
- CE Broker Reporting
-
- Arkansas State Board of Nursing
- Bahamas Medical Council
- District of Columbia Board of Nursing
- Florida Board of Medicine
- Florida Board of Nursing
- Florida Board of Nursing - Certified Nursing Assistants
- Florida Board of Osteopathic Medicine
- Florida Physician Assistants
- Georgia Board of Nursing
- Georgia Composite Medical Board - Physician Assistants
- Georgia Composite Medical Board - Physicians & Telemedicine
- Kansas State Board of Nursing
- Kentucky Board of Nursing
- Louisiana State Board of Medical Examiners - Physicians & Surgeons
- Michigan Board of Nursing
- Mississippi Board of Nursing
- Mississippi State Board of Medical Licensure
- New Hampshire Board of Medicine
- New Hampshire Board of Nursing
- New Mexico Board of Nursing
- New Mexico Certified Nurse Midwives and Licensed Midwives
- New Mexico Medical Board
- North Dakota Board of Nursing
- Oklahoma Board of Medical Licensure and Supervision - Medical Doctors
- Oklahoma Board of Medical Licensure and Supervision - Physician Assistants
- South Carolina Board of Examiners in Optometry
- South Carolina Board of Medical Examiners
- South Carolina Board of Nursing
- State Medical Board of Ohio
- Tennessee Board of Medical Examiners
- Tennessee Board of Osteopathic Examination
- Texas Optometry Board
- West Virginia Board of Registered Nurses
- Wisconsin Medical Examining Board
- Wyoming Board of Nursing
CE Accreditation
- Accrediting CEs
-
Jointly provided by Partners for Advancing Clinical Education (PACE) and Premiere Education.
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Premiere Education. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1 contact hour(s).
Designated for 0.25 contact hour(s) of pharmacotherapy credit for Advance Practice Registered Nurses.Physician Continuing Education
PACE designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
COPE Credit
Partners for Advancing Clinical Education is accredited by COPE to provide continuing education to optometrists.
Credit Statement: This course is COPE approved for 1 hour(s) of CE credit. Activity #128094 and Course ID 90641-TD. Check with your local state licensing board to see if this counts toward your CE requirement for re-licensure.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 1 Interprofessional Continuing Education (IPCE) credit(s) for learning and change.
- Instructions for CE Credit
-
Participation in this self-study activity should be completed in approximately 1 hour(s). To successfully complete this activity and receive CE credit, learners must follow these steps during the period from March 13, 2024 through March 13, 2027:
- Review objectives and disclosures
- Study the educational content
- Successfully complete activity assessment(s)
- Complete the activity evaluation
You must receive an assessment score of at least 80% and respond to all evaluation questions to receive a certificate.
Disclosures
- Disclosures
-
Disclosure of Conflicts of Interest
PACE requires planners, faculty, and other individuals who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
Faculty: The faculty reported the following financial relationships or relationships to products or devices they have with ineligible companies:
-
Erika Anderson, OD, FAAO
Staff Optometrist / Independent Contractor, Eye Associates of New Mexico
• has no relevant financial relationships with ineligible companies to disclose -
Grace Murphy, MSN/MPH, RN
Lecturer I, University of New Mexico College of Nursing
• has no relevant financial relationships with ineligible companies to disclose
Planners & Managers & Translators: The PACE & Premiere Education planners and others have no relevant financial relationship(s) to disclose with ineligible companies.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
-
Erika Anderson, OD, FAAO